The company has never made a profit and has relied on investors since 2014. They are trying to recoup their entire $4 billion of investor money in as short as time as possible.
Since the rate of pancreatic cancer is 11.3/100K people per year. The entire customer base is around 40,000 per year in the U.S. Say each of them is on the drug for 12 months, the entire potential market at $40,000 per month is 1.6 billion. This will pay back the investors in 4-6 years and generate insane profits for them for another 15 years after that. A potential 24billion sales on 4 billion in investment.
Higher government funding into research especially in grants to private businesses, only increases the companies profits. It doesn't speed up the research process or reduce the cost of drugs.
If the government funds the research, they should have ownership of the resulting drugs not the private entity. Funding research or development on public funds and allowing private profits is a top reason for the insane prices on drugs.